Constab Pharmaceutical Inc.

Constab Pharmaceutical Inc. (Constab) is a biotechnology company. It has developed a unique novel OncoShuttle technology which delivers anti-cancer drugs directly to cancer cells. The most cancers express AFP receptors (AFPR), this technology can be used to treat the majority of cancers and improve quality of life. Constab has developed a drug candidate called Aimpila which combines its proprietary drug-delivery platform OncoShuttle to a powerful apoptosis inducer. Aimpila has been tested in animal models and in human with various solid tumours. The company is collaborating and financing opportunities to commence its pre-clinical and clinical program and also licensing partners for its anticancer drug delivery technology. Constab is headquartered in Ontario, Canada.

Street: 
800 Petrolia Road, unit 3
City: 
Ontario M3K 3K4
Federal State : 
Canada
WebSite: 
www.constabpharma.com
Fax: 
1-416-6617830

Company Index Score

Current Index Score Historical Index Score
  • Constab Pharmaceutical Inc. currently scores 50 % in the index.
  • Constab Pharmaceutical Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Constab Pharmaceutical Inc. is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets